According to Voyager Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.65312. At the end of 2023 the company had a P/S ratio of 1.49.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.49 | -74.2% |
2022 | 5.76 | 109.4% |
2021 | 2.75 | 76.1% |
2020 | 1.56 | -68.31% |
2019 | 4.93 | -87.66% |
2018 | 39.9 | -22.66% |
2017 | 51.6 | 115.66% |
2016 | 23.9 | -24% |
2015 | 31.5 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |